Innovation
Australian innovation pilot aims to reduce cost of vaccination in developing world
GSK has invested $7.7 million in a new pilot vaccine facility with the hope Australian manufacturing innovation could reduce cost of vaccination in developing world.
Patients & consumers
Giving babies a healthier start
Why are our scientists researching how to adapt an ingredient in mouthwash into a gel for newborn babies?
Patients & consumers
Crowd sourcing new treatments for malaria
New medicines are urgently needed for diseases of the developing world and those medicines need to be affordable.